Merck KGaA

Insider Reports History

Entity
Company
Location
Frankfurter Str. 250, Darmstadt, Germany
Signature
/s/ Christian Uhrich, Authorized signatory of Merck KGaA, Darmstadt, Germany
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Merck KGaA:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 681K $565K $0.83 Oct 26, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Oct 26, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Preferred Srock 0 Oct 26, 2021 Indirect

Insider Reports Filed by Merck KGaA

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Oct 26, 2021 4 $0 4 Oct 26, 2021 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner